US: Obama commends positive moves toward Ebola vaccine

New York, US (PANA) - US President Barack Obama has congratulated scientists at the US National Institutes of Health (NIH) on the first published results from Phase 1 human clinical trials of a promising Ebola vaccine candidate.

A White House statement, obtained by PANA in New York on Thursday, stated: "This candidate has shown initial promise to prevent the spread of the Ebola virus infection."  

"The outstanding work of the NIH, the US Centers for Disease Control and Prevention, the US Food and Drug Administration, and the Biomedical Advanced Research and Development Authority to conduct expedited vaccine trials is evidence of the administration’s determination to mount an aggressive, whole-of-government response to the Ebola crisis.

"The news is another important milestone in that effort, and lays the groundwork for the critical clinical trials to follow shortly in Ebola-impacted countries to determine the safety and efficacy of Ebola vaccine candidates on a larger scale," it said.

The statement said in appreciation of the achievement of the NIH team, and to discuss progress on other fronts on the fight against Ebola, Obama would visit NIH headquarters at Bethesda, Maryland, on 2 December.

"Additionally, the President will use the visit to make the case for prompt US Congress action on his emergency funding request to combat Ebola at home and abroad," it added.

NIH is an agency of the US Department of Health and Human Services and is the country's research agency which makes medical discoveries that improve health and save lives.

NIH is made up of 27 institutes and centers in the US, each with a specific research agenda, focusing on particular diseases or body systems.

-0- PANA AA/AR  27Nov2014

27 november 2014 16:51:08

xhtml CSS